Alimta
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
In patients with metastatic nonsquamous non–small-cell lung cancer (NSCLC), first-line pembrolizumab (Keytruda, Merck) with…
Autoři se zabývaji Registrem Alimta - nemalobuněcný karcinom
plic (NSCLC) a maligni pleuralni mezoteliom (MPM)
10-year follow-up of gene-modified adenoviral-based therapy in 146 non-small-cell lung cancer patients
A135 This pilot study investigated the mechanism of action of PDX and its differences from other antifolates, and compared the in…
Malignant Pleural Mesothelioma is regarded as a tumour, which lacks chemo-sensitivity. However, patients are able to benefit from…
The FDA has made great strides over the past twenty years in loosening drug approval regulations to speed important, life-saving…
No known cure exists for malignant pleural mesothelioma (MPM). The prognosis for patients with this relatively rare, asbestos…
The impact of p53 status on cellular sensitivity to antifolate drugs has been examined in seven human cell lines (A549, MCF7, T…